Capricor (CAPR) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: Globe and Mail, The
Chief Financial Officer — Anthony J. Bergmann Need a quote from a Motley Fool analyst? Email pr@fool.com RISKS CEO Marbán said, "The pricing structure embedded in our commercialization and distribution agreement with NS Pharma contains a fundamental flaw that if left unaddressed would make it economically impossible to deliver Deramiocel to patients covered by Medicare, Medicaid or private insurance." Providers would face potentially hundreds of thousands of dollars in reimbursement shortfalls per dose. This is not a commercial preference. It is a structural barrier to patient access. Management is not expecting further milestone payments from NS Pharma due to the litigation and legal assessment that "the agreement as it stands is non," which may require repayment of up to $50 million in previously received payments if rescission is ordered. CEO Marbán stated that the company is not guiding towards an actual launch date as yet, introducing uncertainty in the timing of lau
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Capricor Therapeutics Eyes FDA Approval Path for Duchenne Cell Therapy [Yahoo! Finance]Yahoo! Finance
- Capricor Therapeutics, Inc. (CAPR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Capricor Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
- Deramiocel Outlook Strengthens Capricor Therapeutics, Inc. (CAPR) as a Small-Cap Stock to Buy [Yahoo! Finance]Yahoo! Finance
- Capricor: I Rate It A Buy After Stress-Testing The Sell Thesis [Seeking Alpha]Seeking Alpha
CAPR
Earnings
- 5/12/26 - Miss
CAPR
Analyst Actions
- 5/13/26 - HC Wainwright
CAPR
Sec Filings
- 6/8/26 - Form 8-K
- 5/28/26 - Form 4
- 5/28/26 - Form 3
- CAPR's page on the SEC website